640 related articles for article (PubMed ID: 30322337)
1. Autophagy: A new strategy for host-directed therapy of tuberculosis.
Paik S; Kim JK; Chung C; Jo EK
Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
[TBL] [Abstract][Full Text] [Related]
2. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.
Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X
mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154
[TBL] [Abstract][Full Text] [Related]
3. TRIM27 elicits protective immunity against tuberculosis by activating TFEB-mediated autophagy flux.
Zhao D; Qiang L; Lei Z; Ge P; Lu Z; Wang Y; Zhang X; Qiang Y; Li B; Pang Y; Zhang L; Liu CH; Wang J
Autophagy; 2024 Jul; 20(7):1483-1504. PubMed ID: 38390831
[TBL] [Abstract][Full Text] [Related]
4. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D - A host directed autophagy mediated therapy for tuberculosis.
Periyasamy KM; Ranganathan UD; Tripathy SP; Bethunaickan R
Mol Immunol; 2020 Nov; 127():238-244. PubMed ID: 33039674
[TBL] [Abstract][Full Text] [Related]
6. The Macrophage Response to
Maphasa RE; Meyer M; Dube A
Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Induction as a Host-Directed Therapeutic Strategy against
Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
9. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. Berbamine promotes macrophage autophagy to clear
Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the mTOR Pathway for Tuberculosis Treatment.
Singh P; Subbian S
Front Microbiol; 2018; 9():70. PubMed ID: 29441052
[TBL] [Abstract][Full Text] [Related]
13. Host-Directed Therapeutic Strategies for Tuberculosis.
Kolloli A; Subbian S
Front Med (Lausanne); 2017; 4():171. PubMed ID: 29094039
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.
Silwal P; Paik S; Kim JK; Yoshimori T; Jo EK
Front Cell Infect Microbiol; 2021; 11():633360. PubMed ID: 33828998
[No Abstract] [Full Text] [Related]
15. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.
Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC
Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194
[TBL] [Abstract][Full Text] [Related]
16. An Interplay Between Autophagy and Immunometabolism for Host Defense Against Mycobacterial Infection.
Paik S; Jo EK
Front Immunol; 2020; 11():603951. PubMed ID: 33262773
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Ursolic Acid Promotes Autophagy by Inhibiting Akt/mTOR and TNF-α/TNFR1 Signaling Pathways to Alleviate Pyroptosis and Necroptosis in Mycobacterium tuberculosis-Infected Macrophages.
Shen J; Fu Y; Liu F; Ning B; Jiang X
Inflammation; 2023 Oct; 46(5):1749-1763. PubMed ID: 37212951
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-activating strategies to promote innate defense against mycobacteria.
Kim YS; Silwal P; Kim SY; Yoshimori T; Jo EK
Exp Mol Med; 2019 Dec; 51(12):1-10. PubMed ID: 31827065
[TBL] [Abstract][Full Text] [Related]
20. Trehalose limits opportunistic mycobacterial survival during HIV co-infection by reversing HIV-mediated autophagy block.
Sharma V; Makhdoomi M; Singh L; Kumar P; Khan N; Singh S; Verma HN; Luthra K; Sarkar S; Kumar D
Autophagy; 2021 Feb; 17(2):476-495. PubMed ID: 32079455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
